Innovision IPO Day 5: Issue booked 30% so far, price band cut to ₹494-519. GMP hints 4% listing pop. Apply or skip?

-28.2

Market Impact Score

-100 Bearish+100 Bullish

AI Analysis

Weak IPO demand can reflect broader investor sentiment towards new listings or specific sector valuations. A lower price band might attract some investors but also signals underlying issues.

Trading Insight

Avoid subscribing to the Innovision IPO unless a significant improvement in subscription rates or a compelling valuation emerges.

Quick check: SUNPHARMA bullish bias (-1.4% 1d), CIPLA neutral (-0.6% 1d).

Key Evidence

•Innovision IPO extended to March 17.
•Price band lowered to ₹494-519 per share.
•Issue booked only 30% so far.
•Company aims to raise ₹322.84 crore for debt reduction and working capital.
•Risk flag: Low subscription rates

Sectors:pharma

AI-powered analysis by

Anadi Algo News